-
1
-
-
33846939792
-
Cooper Survival after hepatic resection in metastatic colorectal cancer: A population-based study
-
Published Online: 19 Jan 2007
-
LINDA C. CUMMINGS, JONATHAN D. PAYES, GREGORY S. Cooper Survival after hepatic resection in metastatic colorectal cancer: A population-based study, Cancer, 718-726 Published Online: 19 Jan 2007,
-
Cancer
, pp. 718-726
-
-
Cummings, L.C.1
Payes, J.D.2
Gregory, S.3
-
2
-
-
0029881854
-
Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients
-
Association Francaise de Chirurgie
-
NORDLINGER B, GUIGUET M, VAILLANT JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer. 1996; 77: 1254-1262
-
(1996)
Cancer
, vol.77
, pp. 1254-1262
-
-
Nordlinger, B.1
Guiguet, M.2
Vaillant, J.C.3
-
3
-
-
0032791959
-
Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery
-
GIACCHETTI S, ITZHAKI M, GRUIA G, et al. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol. 1999; 10: 663-669
-
(1999)
Ann Oncol
, vol.10
, pp. 663-669
-
-
Giacchetti, S.1
Itzhaki, M.2
Gruia, G.3
-
4
-
-
0028114794
-
Experience in hepatic resection for metastatic colorectal cancer: Analysis of clinical and pathologic risk factors
-
GAYOWSKI TJ, IWATSUKI S, MADARIAGA, et al. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery. 1994; 116: 703-710
-
(1994)
Surgery
, vol.116
, pp. 703-710
-
-
Gayowski, T.J.1
Madariaga, I.S.2
-
5
-
-
0027207599
-
Surgical treatment of liver metastases in patients with colorectal cancer
-
BALLANTYNE GH, QUIN J. Surgical treatment of liver metastases in patients with colorectal cancer. Cancer. 1993; 71 (12 Suppl): 4252-4266 (Pubitemid 23169104)
-
(1993)
Cancer
, vol.71
, Issue.12 SUPPL.
, pp. 4252-4266
-
-
Ballantyne, G.H.1
Quin, J.2
-
6
-
-
0038600610
-
Chemotherapy and surgery: New perspectives on the treatment of unresectable liver metastases
-
ADAM R. Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases. Ann Oncol. 2003; 14 Suppl 2: ii13-6.
-
(2003)
Ann Oncol
, vol.14
, Issue.SUPPL. 2
-
-
Adam, R.1
-
7
-
-
0036787717
-
Biweekly chemotherapy with oxaliplatin, irinotecan, infusional Fluorouracil, and leucovorin: A pilot study in patients with metastatic colorectal cancer
-
FALCONE A, MASI G, ALLEGRINI G, et al. Biweekly chemotherapy with oxaliplatin, irinotecan, infusional Fluorouracil, and leucovorin: a pilot study in patients with metastatic colorectal cancer. J Clin Oncol. 2002; 20: 4006-4014
-
(2002)
J Clin Oncol
, vol.20
, pp. 4006-4014
-
-
Falcone, A.1
Masi, G.2
Allegrini, G.3
-
8
-
-
0029794696
-
Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy
-
DOI 10.1097/00000658-199610000-00009
-
BISMUTH H, ADAM R, LEVI F, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg. 1996; 224: 509-522 (Pubitemid 26337559)
-
(1996)
Annals of Surgery
, vol.224
, Issue.4
, pp. 509-522
-
-
Bismuth, H.1
Adam, R.2
Levi, F.3
Farabos, C.4
Waechter, F.5
Castaing, D.6
Majno, P.7
Engerran, L.8
-
9
-
-
0032791959
-
Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery
-
GIACCHETTI S, ITZHAKI M, GRUIA G, et al. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol. 1999; 10: 663-669
-
(1999)
Ann Oncol
, vol.10
, pp. 663-669
-
-
Giacchetti, S.1
Itzhaki, M.2
Gruia, G.3
-
10
-
-
0035018397
-
Five-year survival following hepatic resection after neoadjuvant therapy for non-resectable colorectal
-
ADAM R, AVISAR E, ARICHE A, et al. Five-year survival following hepatic resection after neoadjuvant therapy for non-resectable colorectal. Ann Surg Oncol. 2001; 8: 347-353
-
(2001)
Ann Surg Oncol
, vol.8
, pp. 347-353
-
-
Adam, R.1
Avisar, E.2
Ariche, A.3
-
11
-
-
33644819672
-
Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: A North Central Cancer Treatment Group phase II study
-
ALBERTS SR, HORVATH WL, STERNFELD WC, et al. Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study. J Clin Oncol. 2005; 23: 9243-9249
-
(2005)
J Clin Oncol
, vol.23
, pp. 9243-9249
-
-
Alberts, S.R.1
Horvath, W.L.2
Sternfeld, W.C.3
-
12
-
-
2642541197
-
Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients
-
DOI 10.1093/annonc/mdh217
-
POZZO C, BASSO M, CASSANO A, et al. Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann Oncol. 2004; 15: 933-939 (Pubitemid 39004350)
-
(2004)
Annals of Oncology
, vol.15
, Issue.6
, pp. 933-939
-
-
Pozzo, C.1
Basso, M.2
Cassano, A.3
Quirino, M.4
Schinzari, G.5
Trigila, N.6
Vellone, M.7
Guiliante, F.8
Nuzzo, C.9
Barone, C.10
-
13
-
-
33645269821
-
Triplet therapy with oxaliplatin, irinitecan, 5-fluorouracil and folinic acid within combined modality approach in patients with liver metastases from colorectal cancer
-
abstr 3593
-
de la CAMARA J, RODRIGUEZ J, ROTELLAR F, et al. Triplet therapy with oxaliplatin, irinitecan, 5-fluorouracil and folinic acid within combined modality approach in patients with liver metastases from colorectal cancer Proc Am Soc Clin Oncol, 2004, abstr 3593
-
(2004)
Proc Am Soc Clin Oncol
-
-
De La Camara, J.1
Rodriguez, J.2
Rotellar, F.3
-
14
-
-
10744229419
-
European Association for Research in Oncology, Creteil, France. Multimodal therapy with intravenous biweekly leucovorin, 5-fluorouracil and irinotecan combined with hepatic arterial infusion pirarubicin in non-resectable hepatic metastases from colorectal cancer (a European Association for Research in Oncology trial)
-
ZELEK L, BUGAT R, CHERQUI D, et al; European Association for Research in Oncology, Creteil, France. Multimodal therapy with intravenous biweekly leucovorin, 5-fluorouracil and irinotecan combined with hepatic arterial infusion pirarubicin in non-resectable hepatic metastases from colorectal cancer (a European Association for Research in Oncology trial). Ann Oncol. 2003; 14: 1537-1542
-
(2003)
Ann Oncol
, vol.14
, pp. 1537-1542
-
-
Zelek, L.1
Bugat, R.2
Cherqui, D.3
-
15
-
-
15744374738
-
Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma
-
DOI 10.1200/JCO.2005.00.349
-
LEONARD GD, BRENNER B, KEMENY NE. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol. 2005; 23: 2038-2048 (Pubitemid 46211384)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.9
, pp. 2038-2048
-
-
Leonard, G.D.1
Brenner, B.2
Kemeny, N.E.3
-
16
-
-
0033989203
-
Phase III multicenter randomized trial of oxaliplatin added to chrono-modulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer
-
GIACCHETTI S, PERPOINT B, ZIDANI R, et al. Phase III multicenter randomized trial of oxaliplatin added to chrono-modulated fluorouracil- leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol. 2000; 18: 136-147
-
(2000)
J Clin Oncol
, vol.18
, pp. 136-147
-
-
Giacchetti, S.1
Perpoint, B.2
Zidani, R.3
-
17
-
-
84906140174
-
Resection of previously unresectable liver metastases from colorectal cancer (LMCRC) after chemotherapy (CT) with CPT-11/L13 OHP/LV5FU (Folfirinox): A prospective phase II trial
-
QUENET F, NORDLINGER B, RIVOIRE M, et al. Resection of previously unresectable liver metastases from colorectal cancer (LMCRC) after chemotherapy (CT) with CPT-11/L13 OHP/LV5FU (Folfirinox): A prospective phase II trial. Proc Am Soc Clin Oncol, 2002, 21: 143a
-
(2002)
Proc Am Soc Clin Oncol
, vol.21
-
-
Quenet, F.1
Nordlinger, B.2
Rivoire, M.3
-
18
-
-
2942638081
-
XELOX (capecitabine plus oxaliplatin): Active first-line therapy for patients with metastatic colorectal cancer
-
DOI 10.1200/JCO.2004.11.069
-
CASSIDY J, TABERNERO J, TWELVES C, et al. XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer. J Clin Oncol. 2004; 22: 2084-2091 (Pubitemid 41095141)
-
(2004)
Journal of Clinical Oncology
, vol.22
, Issue.11
, pp. 2084-2091
-
-
Cassidy, J.1
Tabernero, J.2
Twelves, C.3
Brunei, R.4
Butts, C.5
Conroy, T.6
Debrand, F.7
Figer, A.8
Grossmann, J.9
Sawada, N.10
Schoffski, P.11
Sobrero, A.12
Van Cutsein, E.13
Diaz-Rubio, E.14
-
19
-
-
33749016960
-
Safety and efficacy of oxaliplatin/fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer (mCRC): Final analysis of the TREE-Study
-
Abs: 3510
-
Safety and efficacy of oxaliplatin/fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer (mCRC): Final analysis of the TREE-Study. J Clin Oncol 24, 2006: Abs: 3510
-
(2006)
J Clin Oncol
, vol.24
-
-
-
21
-
-
0033050165
-
Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer
-
BLUM JL, JONES SE, BUZDAR AU, et al. Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer. J Clin Oncol. 1999 Feb; 17: 485-493 (Pubitemid 29075232)
-
(1999)
Journal of Clinical Oncology
, vol.17
, Issue.2
, pp. 485-493
-
-
Blum, J.L.1
Jones, S.E.2
Buzdar, A.U.3
Lorusso, P.M.4
Kuter, I.5
Vogel, C.6
Osterwalder, B.7
Burger, H.-U.8
Brown, C.S.9
Griffin, T.10
-
22
-
-
0002294519
-
Results of resection of metastatic tumors of the liver
-
Jan
-
WOODINGTON GF, WAUGH JM. Results of resection of metastatic tumors of the liver. Am J Surg. 1963 Jan; 105: 24-29
-
(1963)
Am J Surg
, vol.105
, pp. 24-29
-
-
Woodington, G.F.1
Waugh, J.M.2
-
23
-
-
0026761374
-
Hepatic resection following systemic chemotherapy for metastatic colorectal carcinoma
-
FOWLER WC, EISENBERG BL, HOFFMAN JP. Hepatic resection following systemic chemotherapy for metastatic colorectal carcinoma. J Surg Oncol. 1992; 51: 122-125
-
(1992)
J Surg Oncol
, vol.51
, pp. 122-125
-
-
Fowler, W.C.1
Eisenberg, B.L.2
Hoffman, J.P.3
-
24
-
-
23844448040
-
Neoadjuvant treatment of unresectable colorectal liver metastases: Correlation between tumour response and resection rates
-
DOI 10.1093/annonc/mdi246
-
FOLPRECHT G, GROTHEY A, ALBERTS S, et al. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol. 2005; 16: 1311-1319 (Pubitemid 41158476)
-
(2005)
Annals of Oncology
, vol.16
, Issue.8
, pp. 1311-1319
-
-
Folprecht, G.1
Grothey, A.2
Alberts, S.3
Raab, H.-R.4
Kohne, C.-H.5
-
25
-
-
6444243519
-
An international phase II study of cetuximab in combination with oxaliplatin/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFOX-4) in the first line treatment of patients with metastatic colorectal cancer (CRC) expressing Epidermal Growth Factor Receptor (EGFR). Preliminary results
-
abstr 3512
-
TABERNO J, VAN CUSTEM E, SASTRE J, et al. An international phase II study of cetuximab in combination with oxaliplatin/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFOX-4) in the first line treatment of patients with metastatic colorectal cancer (CRC) expressing Epidermal Growth Factor Receptor (EGFR). Preliminary results. Proc Am Soc Clin Oncol, 2004, 23: abstr 3512
-
(2004)
Proc Am Soc Clin Oncol
, vol.23
-
-
Taberno, J.1
Van Custem, E.2
Sastre, J.3
-
26
-
-
16244372110
-
Cetuximab + FOLFIRI as first line treatment for metastatic colorectal CA
-
abstr 3513
-
ROUGIER P, RAOUL JL, VAN LAETHEM JL, et al. Cetuximab + FOLFIRI as first line treatment for metastatic colorectal CA. Proc Am Soc Clin Oncol, 2004, 23: abstr 3513
-
(2004)
Proc Am Soc Clin Oncol
, vol.23
-
-
Rougier, P.1
Raoul, J.L.2
Van Laethem, J.L.3
-
27
-
-
6444230253
-
A phase II study of gefinitib in combination with FOLFOX-4 (IFOX) in patients with metastatic colorectal cancer
-
abstr 3514
-
FISHER GA, KUO T, CHO CD, et al. A phase II study of gefinitib in combination with FOLFOX-4 (IFOX) in patients with metastatic colorectal cancer. Proc Am Soc Clin Oncol, 2004, 23: abstr 3514
-
(2004)
Proc Am Soc Clin Oncol
, vol.23
-
-
Fisher, G.A.1
Kuo, T.2
Cho, C.D.3
-
28
-
-
2542561964
-
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
-
DOI 10.1056/NEJMoa032691
-
HURWITZ H, FEHRENBACHER L, NOVOTNY W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004 Jun 3; 350: 2335-2342 (Pubitemid 38702844)
-
(2004)
New England Journal of Medicine
, vol.350
, Issue.23
, pp. 2335-2342
-
-
Hurwitz, H.1
Fehrenbacher, L.2
Novotny, W.3
Cartwright, T.4
Hainsworth, J.5
Heim, W.6
Berlin, J.7
Baron, A.8
Griffing, S.9
Holmgren, E.10
Ferrara, N.11
Fyfe, G.12
Rogers, B.13
Ross, R.14
Kabbinavar, F.15
-
29
-
-
0042130358
-
Oxaliplatin and capecitabine chemotherapy for advanced colorectal cancer: A single institution's experience
-
DOI 10.1016/S0936-6555(03)00019-0
-
SUMPTER K, HARPER-WYNNE C, CUNNINGHAM D, et al. Oxaliplatin and capecitabine chemotherapy for advanced colorectal cancer: a single institution's experience. Clin Oncol (R Coll Radiol). 2003; 15: 221-226 (Pubitemid 36950001)
-
(2003)
Clinical Oncology
, vol.15
, Issue.5
, pp. 221-226
-
-
Sumpter, K.1
Harper-Wynne, C.2
Cunningham, D.3
Gillbanks, A.4
Norman, A.R.5
Hill, M.6
-
30
-
-
0036533777
-
Phase II study of capecitabine and oxaliplatin in first-and second-line treatment of advanced or metastatic colorectal cancer
-
DOI 10.1200/JCO.2002.07.087
-
BORNER MM, DIETRICH D, STUPP R, et al. Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer. J Clin Oncol. 2002; 20: 1759-1766 (Pubitemid 34273264)
-
(2002)
Journal of Clinical Oncology
, vol.20
, Issue.7
, pp. 1759-1766
-
-
Borner, M.M.1
Dietrich, D.2
Stupp, R.3
Morant, R.4
Honegger, H.5
Wernli, M.6
Herrmann, R.7
Pestalozzi, B.C.8
Saletti, P.9
Hanselmann, S.10
Muller, S.11
Brauchli, P.12
Castiglione-Gertsch, M.13
Goldhirsch, A.14
Roth, A.D.15
-
31
-
-
0141725528
-
Phase II study of capecitabine and oxaliplatin as first-line treatment in advanced colorectal cancer
-
DOI 10.1093/annonc/mdg360
-
ZEULI M, NARDONI C, PINO MS, et al. Phase II study of capecitabine and oxaliplatin as first-line treatment in advanced colorectal cancer. Ann Oncol. 2003; 14: 1378-1382 (Pubitemid 37185283)
-
(2003)
Annals of Oncology
, vol.14
, Issue.9
, pp. 1378-1382
-
-
Zeuli, M.1
Nardoni, C.2
Pino, M.S.3
Gamucci, T.4
Gabriele, A.5
Ferraresi, V.6
Giannarelli, D.7
Cognetti, F.8
-
32
-
-
0141852876
-
Influence of postoperative morbidity on longterm survival following liver resection for colorectal metastases
-
LAURENT C, SA CUNHA A, COUDERC P, et al. Influence of postoperative morbidity on longterm survival following liver resection for colorectal metastases. Br J Surg. 2003; 90: 1131-1136
-
(2003)
Br J Surg
, vol.90
, pp. 1131-1136
-
-
Laurent, C.1
Sa Cunha, A.2
Couderc, P.3
-
34
-
-
0030814028
-
Long-term survival following resection of colorectal hepatic metastases. Association Francaise de Chirurgie
-
JAECK D, BACHELLIER P, GUIGUET M, et al. Long-term survival following resection of colorectal hepatic metastases. Association Francaise de Chirurgie. Br J Surg. 1997; 84: 977-980
-
(1997)
Br J Surg
, vol.84
, pp. 977-980
-
-
Jaeck, D.1
Bachellier, P.2
Guiguet, M.3
-
35
-
-
0033504042
-
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases
-
FONG Y, FORTNER J, SUN RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999; 230: 309-318
-
(1999)
Ann Surg
, vol.230
, pp. 309-318
-
-
Fong, Y.1
Fortner, J.2
Sun, R.L.3
-
36
-
-
0842310770
-
Liver resection for colorectal metastases: The third hepatectomy
-
ADAM R, PASCAL G, AZOULAY D, et al. Liver resection for colorectal metastases: the third hepatectomy. Ann Surg. 2003; 238: 871-883
-
(2003)
Ann Surg
, vol.238
, pp. 871-883
-
-
Adam, R.1
Pascal, G.2
Azoulay, D.3
-
37
-
-
0028308472
-
Factors influencing the natural history of colorectal liver metastases
-
STANGL R, ALTENDORF-HOFMANN A, CHARNLEY RM, SCHEELE J. Factors influencing the natural history of colorectal liver metastases. Lancet. 1994; 343: 1405-1410
-
(1994)
Lancet
, vol.343
, pp. 1405-1410
-
-
Stangl, R.1
Altendorf-Hofmann, A.2
Charnley, R.M.3
Scheele, J.4
|